Cytocidal effect of interleukin 1 (IL-1) on HeLa cells is mediated by both soluble and transmembrane tumor necrosis factor (TNF)

Cytokine

Volumn 42, Issue 2, 2008, Pages 243-255

  Doszczak, Małgorzata ^a   Pierzchalski, Arkadiusz ^a   Grzenkowicz, Jolanta ^a   Stasiłojć, Grzegorz ^a   Bigda, Jacek J ^a  

^a Intercollegiate Faculty of Biotechnology   (Poland)

Author keywords

Cytotoxicity; HeLa cells; Interleukin 1; Tumor necrosis factor

Indexed keywords

ANTIBODY; CELL EXTRACT; CYCLOHEXIMIDE; INTERLEUKIN 1; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME INHIBITOR;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL LINE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SUPERNATANT;

ANIMALS; CELL LINE; CYTOTOXICITY TESTS, IMMUNOLOGIC; FEMALE; HELA CELLS; HUMANS; INTERLEUKIN-1; MICE; TUMOR NECROSIS FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 43049167394     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.02.009     Document Type: Article

References (36)

1. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
2. Onozaki K., Matsushima K., Aggarwal B.B., and Oppenheim J.J. Human interleukin 1 is a cytocidal factor for several tumor cell lines. J Immunol 135 (1985) 3962-3968
3. Lachman L.B., Dinarello C.A., Llansa N.D., and Fidler I.J. Natural and recombinant human interleukin 1β is cytotoxic for human melanoma cells. J Immunol 136 (1986) 3098-3102
4. Holtmann H., Hahn T., and Wallach D. Interrelated effects of tumor necrosis factor and interleukin 1 on cell viability. Immunobiology 177 (1988) 7-22
5. Hurwitz A., Hernandez E.R., Payne D.W., Dharmarajan A.M., and Adashi E.Y. Interleukin 1 is both morphogenic and cytotoxic to cultured rat ovarian cells: obligatory role for heterologous, contact-independent cell-cell interaction. Endocrinology 131 (1992) 1643-1649
6. Ellman C., Corbett J.A., Misko T.P., McDaniel M., and Beckerman K.P. Nitric oxide mediates interleukin-1-induced cellular cytotoxicity in the rat ovary. J Clin Invest 92 (1993) 3053-3056
7. Mandrup-Poulsen T., Bendtzen K., Nielsen J.H., Bendixen G., and Nerup J. Cytokines cause functional and structural damage to isolated islets of Langerhans. Allergy 40 (1985) 424-429
8. Mandrup-Poulsen T., Bendtzen K., Nerup J., Egeberg J., and Nielsen J.H. Mechanisms of pancreatic islet destruction: dose-dependent cytotoxic effect of soluble blood mononuclear cell mediators on isolated islets of Langerhans. Allergy 41 (1986) 250-259
9. Mandrup-Poulsen T., Bendtzen K., Nerup J., Dinarello C.A., Svenson M., and Nielsen J.H. Affinity-purified human interleukin 1 is cytotoxic to isolated islets of Langerhans. Diabetologia 29 (1986) 63-67
10. Bendtzen K., Mandrup-Poulsen T., Dinarello C.A., Nerup J., Nielsen J.H., and Svenson M. Cytotoxicity of human pI 7 interleukin 1 for pancreatic islets of Langerhans. Science 232 (1986) 1545-1547
11. Mandrup-Poulsen T., Spinas G.A., Prowse S.J., Hansen B.S., Jorgensen D.W., Bendtzen K., et al. Islet cytotoxicity of interleukin 1. Influence of culture conditions and islet donor characteristics. Diabetes 36 (1987) 641-647
12. Rabinovitch A., Sumoski W., Rajotte R.V., and Warnock G.L. Cytotoxic effects of cytokines on human pancreatic inlet wells in monolayer culture. J Clin Endocrinol Metab 71 (1990) 152-156
13. Mahr S., Neumayer N., Gerhard M., Classen M., and Prinz C. IL-1β-induced apoptosis in rat gastric enterochromaffin-like cells is mediated by iNOS, NFκB, and Bax protein. Gastroenterology 118 (2000) 515-524
14. Welsh N., Bendtzen K., and Sandler S. Influence of protease on inhibitory and stimulatory effects of interleukin 1 beta on beta-cell function. Diabetes 40 (1991) 290-294
15. Ling Z., In't Veld P.A., and Pipeleers D.G. Interaction of interleukin 1 with islet β-cells. Distinction between indirect, aspecific cytotoxicity and direct, specific functional suppression. Diabetes 42 (1993) 56-65
16. Vassiliadis S., Dragiotis V., Protopapadakis E., Athanassakis I., Mitlianga P., Konidaris K., et al. The destructive action of IL-1alpha and IL-beta in IDDM is a multistage process: evidence and confirmation by apoptotic studies, induction of intermediates and electron microscopy. Mediators Inflamm 8 (1999) 85-91
17. Le J., and Vilcek J. Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. Lab Invest 56 (1987) 234-248
18. Dinarello C.A. The biological properties of interleukin-1. Eur Cytokine Netw 5 (1994) 517-531
19. Wallach D., Varfolomeev E.E., Malinin N.L., Goltsev Y.V., Kovalenko A.V., and Boldin M.P. TNF receptor and Fas signaling mechanisms. Annu Rev Immunol 17 (1999) 331-367
20. Bigda J., Beletsky I., Brakebush C., Varfolomeev E., Engelmann H., Bigda J., et al. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity. J Exp Med 180 (1994) 445-460
21. Wallach D. Preparations of lymphotoxin induce resistance to their own cytotoxic effect. J Immunol 132 (1984) 2464-2469
22. Gong J., Traganos F., and Darżynkiewicz Z. A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal Biochem 218 (1994) 314-319
23. Dolle R.E., Hoyer D., Prasad C.V., Schmidt S.J., Helas C.T., Miller R.E., et al. Aspartyl alpha-((1-phenyl-3-(trifluoromethyl)-pyrazol-5-yl)oxy) methyl ketones as interleukin-1 beta converting enzyme inhibitors. Significance of the P1 and P3 amido nitrogens for enzyme-peptide inhibitor binding. J Med Chem 37 (1994) 3863-3866
24. Crowe P.D., Walter B.N., Mohler K.M., Otten-Evans C., Black R.A., and Ware C.F. A metalloprotease inhibitor blocks shedding of the 80-kDa TNF receptor and TNF processing in T lymphocytes. J Exp Med 181 (1995) 1205-1210
25. Heitmeier M.R., Scarim A.L., and Corbett J.A. Interferon-γ increases the sensitivity of islets of Langerhans for inducible nitric-oxide synthase expression induced by interleukin 1. J Biol Chem 272 (1997) 13697-13704
26. Kaneto H., Fujii J., Seo H.G., Suzuki K., Matsuoka T., Nakamura M., et al. Apoptotic cell death triggered by nitric oxide in pancreatic β-cells. Diabetes 44 (1995) 733-738
27. Ankarcrona M., Dypbukt J.M., Brune B., and Nibotera P. Interleukin -1β-induced nitric oxide production activates apoptosis in pancreatic RINm5F cells. Exp Cell Res 213 (1994) 172-177
28. Karlsen A.E., Ronn S.G., Lindberg K., Johannesen J., Galsgaard E.D., Pociot F., et al. Suppressor of cytokine signaling 3 (SOCS-3) protects β-cells against interleukin 1β- and interferon γ-mediated cytotoxicity. Proc Natl Acad Sci USA 98 (2001) 12191-12196
29. Zen K., Karsan A., Stempien-Otero A., Yee E., Tupper Y., Li X., et al. NF-κB activation is required for human endothelial survival during exposure to tumor necrosis factor-α but not to interleukin-1β or lipopolysaccharide. J Biol Chem 274 (1999) 28808-28815
30. Grell M., Zimmermann G., Gottfried E., Chen C.M., Gruenwald U., Huang D.C.S., et al. Induction of cell death by tumor necrosis factor (TNF) receptor 2, CD40 and CD30: a role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 18 (1999) 3034-3043
31. Tsuji Y., Watanabe N., Okamoto T., Tsuji N., Sasaki H., Akiyama S., et al. Endogenous tumor necrosis factor functions as a resistant factor against hyperthermic cytotoxicity. Cancer Res 52 (1992) 6258-6262
32. Osipovich O.A., Fegeding K.V., Misuno N.I., Kolesnikova T.S., Savostin I.K., Sudarikov A.B., et al. Differential action of cycloheximide and activation stimuli on transcription of tumor becrosis factor-alpha, IL-1 beta, IL-8, and P53 genes in human monocytes. J Immunol 150 (1993) 4958-4965
33. Knöfler M., Kiss H., Mosl B., Egarter C., and Husslein P. Interleukin 1 stimulates tumor necrosis factor-α (TNF-α) release from cytotrophoblastic BeWo cells independently of induction of the TNF-α mRNA. FEBS Lett 405 (1997) 213-218
34. Kothny-Wilkes G., Kulms D., Luger T.A., Kubin M., and Schwarz T. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand- and CD95-induced apoptosis but not from ultraviolet radiation-induced apoptosis. J Biol Chem 274 (1999) 28916-28921
35. Watanabe N., Tsuji N., Akiyama S., Sasaki H., Okamoto T., Kobayashi D., et al. Induction of heat shock protein 72 synthesis by endogenous tumor necrosis factor via enhancement of the heat shock element-binding activity of heat shock factor 1. Eur J Immunol 27 (1997) 2830-2834
36. Haas E., Grell M., Wajant H., and Scheurich P. Continuous autotropic signaling by membrane-expressed tumor necrosis factor. J Biol Chem 274 (1999) 18107-18112